Emerging Markets Drive Europe’s OTC Growth Despite Global Economic Slump
This article was originally published in The Pink Sheet Daily
Executive Summary
The de-reimbursed markets of France and Germany lag significantly behind the rest of Western Europe in OTC growth while Central and Eastern Europe accounts for 80 percent, despite being the source of just 20 percent of the continent's total drug sales.